| Prev Close: | 56.09 |
|---|---|
| Open: | 55.97 |
| Bid: | N/A |
| Ask: | 59.26 x 1000 |
| 1y Target Est: | 52.67 |
| Beta: | 0.48 |
| Next Earnings Date: | 23-Jul-13 |
| Day's Range: | 55.51 - 56.46 |
|---|---|
| 52wk Range: | 46.08 - 58.92 |
| Volume: | 21,592 |
| Avg Vol (3m): | 41,614 |
| Market Cap: | 737.57M |
| P/E (ttm): | 21.58 |
| EPS (ttm): | 2.59 |
| Div & Yield: | 0.60 (1.10%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- More Smart Meters for C&I MarketZacks(Fri, May 24)
- Microgrids Revenue to Boom: NavigantZacks(Tue, May 14)
- Corp Exec Board Maintains Steady DividendZacks(Tue, May 14)
- EXPONENT INC FinancialsEDGAR Online Financials(Fri, May 10)
- EXPONENT INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 3)
- Navigant's Earnings Excel EstimateZacks(Mon, Apr 29)
- CoreLogic Posts Solid 1Q EarningsZacks(Thu, Apr 25)
- 1 Retailer, 1 Biotech And 1 Management Services Company With Recent Intensive Insider Sellingat Seeking Alpha(Wed, Apr 24)
- Exponent Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, Apr 17)
- Exponent Declares Regular Quarterly DividendGlobeNewswire(Wed, Apr 17)
- Exponent Reports First Quarter Fiscal 2013 ResultsGlobeNewswire(Wed, Apr 17)
- EXPONENT INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial SEDGAR Online(Wed, Apr 17)
- Q1 2013 Exponent Earnings Release - After Market CloseCCBN(Wed, Apr 17)
- Exponent to Announce First Quarter Fiscal 2013 ResultsGlobeNewswire(Wed, Apr 10)
- Mortality, Cost and Health Outcomes of Total Knee Arthroplasty in Medicare PatientsPR Newswire(Wed, Mar 27)
Press Releases
- Exponent Declares Regular Quarterly DividendGlobeNewswire(Wed, Apr 17)
- Exponent Reports First Quarter Fiscal 2013 ResultsGlobeNewswire(Wed, Apr 17)
- Exponent to Announce First Quarter Fiscal 2013 ResultsGlobeNewswire(Wed, Apr 10)
Reports
- EXPO - Exponent Inc - Rated a Hold - Company Analysis and ASR Ranking ReportAlpha Street Research(May 28)
- EXPO: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(May 24)
- ValuEngine Industry Report for ConsultingValuEngine, Inc.(May 24)